Some emerging research has explored potential connections between GLP-1 signalling and thyroid function
Sridhar VS, Dubrofsky L, Boulet J, Cherney DZ
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Singh S, Facciorusso A, Singh AG, VandeCasteele N, Zarrinpar A, Prokop LJ, et al
Clinical trial data showed similar weight loss outcomes between formulations when treatment was adhered to
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: a 12-week, randomized, placebo-controlled, phase 2 study comparing different dose-escalation schemes
By contrast, GLP-1RAs dosing over the long term may only slightly increase systolic blood pressure by 2 mmHg [104]